Spanish National Research Council (CSIC)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Senior Scientist at the Spanish Institute of Oceanography, IEO-CSIC
Virologist (senior scientist) at the Animal Health Research Centre (CISA, INIA-CSIC)
Researcher at the Instituto Cajal, CSIC
Professor of Energy Economics at Durham University (UK) and CSIC research professor
Researcher at the Institute of Public Goods and Policies of the CSIC (IPP-CSIC)
CSIC research professor and expert in food safety and water quality
Head of the Epidemiology and Environmental Health research group at CISA, INIA-CSIC.
Senior scientist at the Institute for Biomedical Research of Barcelona (IIBB-CSIC), principal investigator at CIBERSAM and head of the Systems Neuropharmacology group at IDIBAPS-Fundació Clínic.
Research Professor at the Doñana Biological Station (EBD-CSIC)
Director of the Institute of Neurosciences, a joint centre of the Miguel Hernández University of Elche (UMH) and the CSIC

Using data from the James Webb Space Telescope (JWST), a group of astronomers has detected the chemical fingerprints of dimethyl sulfide (DMS) and dimethyl disulfide (DMDS) in the atmosphere of exoplanet K2-18b, which orbits its star in the habitable zone. The detection has been published in The Astrophysical Journal Letters.

The KATRIN (Karlsruhe Tritium Neutrino Experiment) team has published the most accurate measurement to date of the upper limit of the neutrino mass in the journal Science, establishing it at 0.45 electronvolts (eV), less than a millionth of the mass of an electron. The KATRIN experiment, launched in 2018 in Germany, will finalise its neutrino mass measurement campaign this year, having reached 1,000 days of data acquisition.

Only 9.5% of plastics produced globally in 2022 were generated from recycled materials. The findings, published in Communications Earth & Environment, are part of a comprehensive analysis of the global plastics sector, which also reveals a large increase in the amount of plastic being disposed of by incineration and substantial regional differences in its consumption.

While some studies have suggested that having a mother with Alzheimer's may increase the risk of developing the disease, a new study reveals that having a father with the disease may be related to a greater spread of tau protein in the brain, which is a sign of the disease. The study, published in Neurology, does not prove that having a father with Alzheimer's causes these brain changes; it only shows an association.

A set of articles published in Nature and Nature Methods draws a high-resolution map of the structure of and connections between the brain cells of mice. The map is based on data from a single cubic millimetre of brain and includes more than 200,000 cells, around 84,000 neurons and 524 million synaptic connections. Although this is a very small part of the mouse brain, it will help us understand how different types of cells work together.

An international team with Spanish participation has analysed the usefulness of a blood biomarker - the p-tau217 protein - for detecting Alzheimer's disease in 1,767 patients. According to the authors, who publish the results in the journal Nature Medicine, the test has detected the disease with high reliability in four hospital cohorts, as well as in a primary care cohort. They add that it is an assay that can be easily implemented in clinical laboratories and is already routinely used in some centres in Spain.

EMA’s human medicines committee has recommended not authorising the marketing of Kisunla (donanemab), a drug intended for the treatment of early-stage Alzheimer's disease. The committee considered that the benefits of this drug were not great enough to outweigh the risk of potentially fatal events. In recent years, several patients have died due to microbleeds in the brain.

A team in the US has tested the efficacy of baloxavir, an antiviral already on the market for treating common flu, against avian influenza in mice. The results, published in the journal Nature Microbiology, show that it is more effective than the currently recommended oseltamivir (Tamiflu) except when the infection is via the mouth, in which case it is equally effective. According to the authors, baloxavir ‘could be considered for the potential treatment of serious H5N1 virus infections in humans’.

23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long covid and more than half of them had persistent symptoms for two years. These are the main conclusions of a study led by ISGlobal that followed more than 2,700 people in Catalonia. The results are published in the journal BMC Medicine.

Colossal Biosciences has announced the creation of genetically modified mice with characteristics reminiscent of the fur of extinct mammoths, such as fur colour, texture and thickness. The non-peer-reviewed results were shared today in the BioRXiv prepublication repository.